Tag: randomized control trials

ISPOR 22nd Annual International Meeting Drew Key Stakeholders and Thought Leaders to Discuss Social and Policy Changes in Health Care

Largest Attendance to Date for the Society’s International Meeting   Princeton, NJ—June 5, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently concluded its 22nd Annual International Meeting in Boston, MA, USA. The conference attracted 4,195 delegates representing 76

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , ,

Is Big Data Eclipsing the Role of Randomized Controlled Trials?

Renowned Researchers and Health Policy Experts Weigh In Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted its third and final plenary session this morning focusing on the usefulness of big data in health care policy

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

ISPOR 22nd Annual International Meeting to Focus on Social and Policy Change in Health Care

Conference to Be Held May 20-24, 2017 in Boston Princeton, NJ—May 9, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading educational and scientific organization for health economics and outcomes research (HEOR), announced confirmation of the scientific sessions

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , ,

ISPOR Announces Plenary Sessions and Speakers For 22nd Annual International Meeting

Conference to Focus on Timely Theme of Evidence and Value in a Time of Social and Policy Change Princeton, NJ—March 6, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 22nd Annual International

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , ,

The International Society For Pharmacoeconomics And Outcomes Research Examines The Role Of Big Data In Health Care Decision Making

Princeton, NJ, USA – Health care researchers, health technology assessors, manufacturers, governments, and patients will examine the role of “Big Data” in health care decision making at the ISPOR 19th Annual International Meeting. The meeting will take place May 31 – June

Posted in ISPOR News & Press Tagged with: , , , ,

Bayesian Methods Can Help To Bring Science Closer To Policy

Nijmegen, The Netherlands – A gap often exists between the questions that policy-makers face and the answers that science provides. Typically, science offers bits and pieces of information that are, at best, partially relevant to the policy problem under consideration.

Posted in Comparative Effectiveness Research / Health Technology Assessment, Value in Health Tagged with: , , , , ,

Expecting A Lot Of Missing Data In Your Resource Use Questionnaire? Give Patients A Resource Use Log Too!

Bristol, UK – Using patient-completed questionnaires to collect resource use in economic evaluations conducted alongside randomised controlled trials (RCTs) often results in missing data. A research team from the University of Bristol designed a log to give patients at baseline so

Posted in Methodological Articles, Value in Health Tagged with: , , , , ,

Innovative Methods Uncover Differential Responders To Treatment

Manchester, UK – Variability in response to treatment (also called heterogeneity of treatment effects) is a common finding in clinical trials. Some variability is hypothesised and expected, such as differences between treatment and placebo groups, across doses, or between comparator drugs.

Posted in Methodological Articles, Value in Health Tagged with: , , , ,